top of page
Anavex President & CEO Christopher U. Missling, PhD, to participate in a roundtable discussion at the World Orphan Drug Congress USA, on April 21.
![Anavex-1-1666x833.png](https://static.wixstatic.com/media/432182_ced8c5c5e2ce4a2db775b0ec5f5b850e~mv2.jpg/v1/fill/w_883,h_423,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Anavex-1-1666x833.jpg)
Anavex President & CEO Christopher U. Missling, PhD, to participate in a roundtable discussion at the World Orphan Drug Congress USA, Friday, at 12:20 PM on April 21.
Wardmar Park Marriott
Washington, DC
Roundtable 4: Partnerships- successful collaboration between a rare disease foundation and a pharmaceutical company to advance preclinical and clinical research in Rett Syndrome.
1/0
bottom of page